CD8A and neoplasm: Studies have found that tumor cells compete with CD8+T for methionine through the high expression of methionine transporter, which reduces the levels of methionine and methyl donor s-adenosylmethionine (SAM) in T cells, and inhibition of transporters enhances immune checkpoint-induced tumor immunity (118).